PGEN
Overvalued by 103.6% based on the discounted cash flow analysis.
Market cap | $348.49 Million |
---|---|
Enterprise Value | $285.63 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.39 |
Beta | 2.06 |
Outstanding Shares | 248,919,096 |
Avg 30 Day Volume | 728,640 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.63 |
---|---|
PEG | -7.41 |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 45.88 |
Enterprise Value to EBIT | -3.21 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data